Titre : Lâchage de suture

Lâchage de suture : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatic Neoplasms
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Lâchage de suture : Questions médicales les plus fréquentes", "headline": "Lâchage de suture : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Lâchage de suture : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-29", "dateModified": "2025-04-23", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Lâchage de suture" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Complications postopératoires", "url": "https://questionsmedicales.fr/mesh/D011183", "about": { "@type": "MedicalCondition", "name": "Complications postopératoires", "code": { "@type": "MedicalCode", "code": "D011183", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.767" } } }, "about": { "@type": "MedicalCondition", "name": "Lâchage de suture", "alternateName": "Surgical Wound Dehiscence", "code": { "@type": "MedicalCode", "code": "D013529", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Emmy Muller-Sloof", "url": "https://questionsmedicales.fr/author/Emmy%20Muller-Sloof", "affiliation": { "@type": "Organization", "name": "Department of Plastic and Reconstructive Surgery, Radboud University Medical Center, P/O Box 9101, 6500 HB, Nijmegen (634), the Netherlands; Department of Vascular Surgery, Erasmus University Medical Center, Dr. Molenwaterplein 40, 3015 GD, Rotterdam (Rg219), the Netherlands. Electronic address: Emmy.Muller-Sloof@radboudumc.nl." } }, { "@type": "Person", "name": "Erik de Laat", "url": "https://questionsmedicales.fr/author/Erik%20de%20Laat", "affiliation": { "@type": "Organization", "name": "Department of Plastic and Reconstructive Surgery, Radboud University Medical Center, P/O Box 9101, 6500 HB, Nijmegen (634), the Netherlands. Electronic address: ermatire@gmail.com." } }, { "@type": "Person", "name": "Hester Vermeulen", "url": "https://questionsmedicales.fr/author/Hester%20Vermeulen", "affiliation": { "@type": "Organization", "name": "Radboud Institute for Health Sciences Scientific Center for Quality of Healthcare, Radboud University Medical Center, P/O Box 9101, 6500 HB, Nijmegen, the Netherlands; HAN University Applied Sciences, Institute of Health, Kapittelweg 54, 6525 EP, Nijmegen, the Netherlands. Electronic address: Hester.Vermeulen@radboudumc.nl." } }, { "@type": "Person", "name": "Stefan Hummelink", "url": "https://questionsmedicales.fr/author/Stefan%20Hummelink", "affiliation": { "@type": "Organization", "name": "Department of Plastic and Reconstructive Surgery, Radboud University Medical Center, P/O Box 9101, 6500 HB, Nijmegen (634), the Netherlands. Electronic address: Stefan.Hummelink@radboudumc.nl." } }, { "@type": "Person", "name": "Kylie Sandy-Hodgetts", "url": "https://questionsmedicales.fr/author/Kylie%20Sandy-Hodgetts", "affiliation": { "@type": "Organization", "name": "Burn Injury Research Unit, School of Biomedical Sciences, Faculty of Medicine, University of Western Australia, UWA Department of Obstetrics, King Edward Memorial Hospital, Perth, Western Australia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Observational Study on Antibody Response to COVID-19 Vaccines in PAtients with Gastro-Entero-PanCreatic Cancers and NeuroendocrIne NeoplAsms on Systemic TreatmEnts (VACCINATE).", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36830873", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/biomedicines11020336" } }, { "@type": "ScholarlyArticle", "name": "Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.", "datePublished": "2022-12-18", "url": "https://questionsmedicales.fr/article/36624015", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clml.2022.12.008" } }, { "@type": "ScholarlyArticle", "name": "Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies.", "datePublished": "2022-12-01", "url": "https://questionsmedicales.fr/article/36632576", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.14740/jh1042" } }, { "@type": "ScholarlyArticle", "name": "A Prediction Model Based on the Risk Factors Associated with Pathological Upgrading in Patients with Early-Stage Gastric Neoplasms Diagnosed by Endoscopic Forceps Biopsy.", "datePublished": "2022-09-02", "url": "https://questionsmedicales.fr/article/36052614", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5009/gnl220060" } }, { "@type": "ScholarlyArticle", "name": "Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database.", "datePublished": "2022-05-12", "url": "https://questionsmedicales.fr/article/35720036", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/3689895" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Complications postopératoires", "item": "https://questionsmedicales.fr/mesh/D011183" }, { "@type": "ListItem", "position": 5, "name": "Lâchage de suture", "item": "https://questionsmedicales.fr/mesh/D013529" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Lâchage de suture - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Lâchage de suture", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Lâchage de suture", "description": "Comment diagnostiquer un lâchage de suture ?\nQuels examens peuvent aider au diagnostic ?\nQuels signes cliniques indiquent un lâchage ?\nQuand consulter un médecin après une chirurgie ?\nLe lâchage de suture est-il visible immédiatement ?", "url": "https://questionsmedicales.fr/mesh/D013529?mesh_terms=Prostatic+Neoplasms&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Lâchage de suture", "description": "Quels sont les symptômes d'un lâchage de suture ?\nLa douleur est-elle un symptôme courant ?\nUn écoulement est-il normal après une chirurgie ?\nComment reconnaître une infection liée au lâchage ?\nLes symptômes varient-ils selon le type de chirurgie ?", "url": "https://questionsmedicales.fr/mesh/D013529?mesh_terms=Prostatic+Neoplasms&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Lâchage de suture", "description": "Comment prévenir un lâchage de suture ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLes soins de plaie sont-ils importants ?\nLe tabagisme influence-t-il le risque de lâchage ?\nLes activités physiques doivent-elles être limitées ?", "url": "https://questionsmedicales.fr/mesh/D013529?mesh_terms=Prostatic+Neoplasms&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Lâchage de suture", "description": "Quel est le traitement principal du lâchage de suture ?\nDes antibiotiques sont-ils nécessaires ?\nComment gérer la douleur liée au lâchage ?\nLe traitement est-il différent pour les enfants ?\nPeut-on traiter un lâchage à domicile ?", "url": "https://questionsmedicales.fr/mesh/D013529?mesh_terms=Prostatic+Neoplasms&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Lâchage de suture", "description": "Quelles complications peuvent survenir ?\nLe lâchage peut-il entraîner une hospitalisation ?\nComment l'infection affecte-t-elle la cicatrisation ?\nLe lâchage de suture peut-il être fatal ?\nLes cicatrices peuvent-elles être esthétiquement inesthétiques ?", "url": "https://questionsmedicales.fr/mesh/D013529?mesh_terms=Prostatic+Neoplasms&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Lâchage de suture", "description": "Quels sont les facteurs de risque du lâchage ?\nL'âge influence-t-il le risque de lâchage ?\nLes antécédents chirurgicaux augmentent-ils le risque ?\nLe contrôle de la glycémie est-il important ?\nLes médicaments immunosuppresseurs augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D013529?mesh_terms=Prostatic+Neoplasms&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un lâchage de suture ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen physique et l'observation de l'ouverture de la plaie." } }, { "@type": "Question", "name": "Quels examens peuvent aider au diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des examens d'imagerie comme l'échographie peuvent être utilisés pour évaluer la plaie." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent un lâchage ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme l'écoulement de liquide ou l'apparition de rougeurs autour de la plaie peuvent indiquer un lâchage." } }, { "@type": "Question", "name": "Quand consulter un médecin après une chirurgie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de consulter si la plaie présente des signes d'infection ou d'ouverture." } }, { "@type": "Question", "name": "Le lâchage de suture est-il visible immédiatement ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, il peut se développer progressivement, nécessitant une surveillance attentive." } }, { "@type": "Question", "name": "Quels sont les symptômes d'un lâchage de suture ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, écoulement, rougeur et ouverture de la plaie." } }, { "@type": "Question", "name": "La douleur est-elle un symptôme courant ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une douleur accrue autour de la plaie peut indiquer un lâchage de suture." } }, { "@type": "Question", "name": "Un écoulement est-il normal après une chirurgie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Un léger écoulement peut être normal, mais un écoulement purulent est préoccupant." } }, { "@type": "Question", "name": "Comment reconnaître une infection liée au lâchage ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme rougeur, chaleur, gonflement et écoulement purulent peuvent indiquer une infection." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de chirurgie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon la localisation et le type de chirurgie effectuée." } }, { "@type": "Question", "name": "Comment prévenir un lâchage de suture ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Suivre les instructions post-opératoires et éviter les efforts physiques excessifs aide à prévenir." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en protéines et en vitamines favorise la cicatrisation." } }, { "@type": "Question", "name": "Les soins de plaie sont-ils importants ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins appropriés de la plaie sont cruciaux pour éviter les infections et le lâchage." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque de lâchage ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut retarder la cicatrisation et augmenter le risque de déhiscence." } }, { "@type": "Question", "name": "Les activités physiques doivent-elles être limitées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est conseillé de limiter les activités physiques intenses pendant la période de cicatrisation." } }, { "@type": "Question", "name": "Quel est le traitement principal du lâchage de suture ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure la réouverture de la plaie et la réfection des sutures." } }, { "@type": "Question", "name": "Des antibiotiques sont-ils nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antibiotiques peuvent être prescrits si une infection est suspectée." } }, { "@type": "Question", "name": "Comment gérer la douleur liée au lâchage ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des analgésiques peuvent être administrés pour soulager la douleur associée au lâchage." } }, { "@type": "Question", "name": "Le traitement est-il différent pour les enfants ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le traitement peut être adapté en fonction de l'âge et de l'état général de l'enfant." } }, { "@type": "Question", "name": "Peut-on traiter un lâchage à domicile ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical est essentiel, mais des soins de plaie peuvent être effectués à domicile sous supervision." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'infection, la réouverture de la plaie et des cicatrices anormales." } }, { "@type": "Question", "name": "Le lâchage peut-il entraîner une hospitalisation ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une hospitalisation peut être nécessaire pour traiter les complications du lâchage." } }, { "@type": "Question", "name": "Comment l'infection affecte-t-elle la cicatrisation ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'infection peut retarder la cicatrisation et augmenter le risque de complications." } }, { "@type": "Question", "name": "Le lâchage de suture peut-il être fatal ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Rarement, mais des complications graves peuvent survenir si non traitées rapidement." } }, { "@type": "Question", "name": "Les cicatrices peuvent-elles être esthétiquement inesthétiques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un lâchage peut entraîner des cicatrices hypertrophiques ou chéloïdes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du lâchage ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'obésité, le diabète, et les infections préexistantes." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de lâchage ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru de déhiscence de plaie." } }, { "@type": "Question", "name": "Les antécédents chirurgicaux augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de déhiscence augmentent le risque lors de futures interventions." } }, { "@type": "Question", "name": "Le contrôle de la glycémie est-il important ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon contrôle de la glycémie est crucial pour réduire le risque de déhiscence chez les diabétiques." } }, { "@type": "Question", "name": "Les médicaments immunosuppresseurs augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ces médicaments peuvent compromettre la cicatrisation et augmenter le risque de lâchage." } } ] } ] }

Sources (10000 au total)

Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.

Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusion (MLN-TK) is an entity encompassed of a heterogeneous group of rare hematopoietic neoplasms that are driven by gene fusion i... The retrospective study included patients with confirmed MLN-TK from 3 centers and assessed demographic and clinical variables, treatment, and outcomes.... Forty-two patients with confirmed MLN-TK [PDGFRA (n = 22), PDGFRB (n = 4), FGFR1(n = 10), JAK2 (n = 2); and FLT3 (n = 3)] were included. Fifteen of 25 (60%) chronic-phased patients received upfront TK... The outcomes of upfront TKI therapy are excellent for MLN-TK in both chronic and blast phases, regardless of gene abnormalities....

A Prediction Model Based on the Risk Factors Associated with Pathological Upgrading in Patients with Early-Stage Gastric Neoplasms Diagnosed by Endoscopic Forceps Biopsy.

The discrepancies between the diagnosis of preoperative endoscopic forceps biopsy (EFB) and endoscopic submucosal dissection (ESD) in patients with early gastric neoplasm (EGN) exist objectively. Amon... We retrospectively collected the records of 978 patients who underwent ESD from December 1, 2017 to July 31, 2021 and who had a final histopathology determination of EGN. A nomogram to predict the ris... The ratio of pathological upgrading was 510 of 953 (53.5%). Clinical, laboratorial and endoscopic characteristics were analyzed using univariable and binary multivariable logistic regression analyses.... The clinical value of identifying the preoperative diagnosis of EGN lesions is limited when using EFB separately. We have developed a nomogram that can predict the probability of pathological upgradin...

Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database.

The incidence of nonfunctional pancreatic neuroendocrine neoplasms (NF-pNENs) has been increasing annually. This study is aimed at investigating the clinicopathological characteristics and high-risk f... pNEN patients in this study were obtained from the Surveillance, Epidemiology, and End Results (SEER) database. This study analyzed patients diagnosed with NF-pNENs from 2000 to 2017 who met the inclu... From 2000 to 2017, the SEER database registered 10576 patients with pNENs and 1774 patients with liver metastases. Cox analysis revealed that age, sex, primary site, grade, tumor stage, surgery, tumor... The incidence of pNENs has been increasing annually, and the liver has been the most common site of metastasis. Liver metastasis in patients with NF-pNENs, related to tumor size and grade, affected th...

Prostate-specific Antigen at 3 Months as a Predictor of Radiologic Progression-free Survival in Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Analysis of 633 Patients in a Real-world Database.

The depth of the prostate-specific antigen (PSA) decline after androgen receptor pathway inhibitor (ARPI) treatment combined with androgen deprivation therapy for patients with metastatic hormone-sens... We conducted a retrospective multicenter study of patients with mHSPC treated with apalutamide from May 2018 to September 2023 registered in the Real-World Evidence APA registry across 20 centers.... We included 633 patients with mHSPC. The median age at diagnosis was 68 yr (interquartile range [IQR] 63-75) and median PSA was 16 ng/ml (IQR 7.5-64). Some 63% of the short had low-volume disease, 51%... Patients with a complete PSA response after 3 mo of apalutamide treatment face a very low risk of progression within 2 yr. Conversely, nearly 50% of patients with an incomplete PSA response will exper... For patients with metastatic prostate cancer that is still responsive to hormone therapy, a complete response after treatment with a drug called apalutamide is associated with a very low risk of progr...

Prevalence of clinically significant prostate carcinoma in Prostate Imaging Reporting and Data System (PIRADS) 3 lesions detected in the peripheral zone on biparametric magnetic resonance imaging (MRI)-a local experience.

The aim of this study was to determine whether biparametric magnetic resonance imaging (MRI) is effective in the diagnosis of clinically significant prostate cancer in prostate peripheral zone Prostat... Patients who underwent biparametric MRI over a 12-month period from January 2022 to December 2022 and were diagnosed with PIRADS 3 lesion in the peripheral zone were included in the study. No patient ... Sixty-one out of 688 MRIs (8.8%) performed over the study period had a PIRADS 3 lesion in the peripheral zone where contrast is supposed to add value. Fifty-eight of the 61 went ahead to biopsy, and c... Biparametric MRI without contrast offers a reliable alternative to multiparametric MRI with minimum or neglible impact on clinically significant prostate cancer (csPCa) diagnosis in peripheral zone PI...

Malignant Epithelioid Mesenchymal Neoplasm with FUS::CREM Gene Fusion Arising in the Tongue: A Case Report Detailing Clinicopathological, Imaging, and Molecular Features.

FUS::CREM fusion is a distinct primary driver in rare neoplasms of the head and neck and other anatomic sites. Herein, we describe the clinicopathological, imaging, and molecular features of a maligna...

Epidemiology, Pattern, and Survival of Multiple Primary Malignant Neoplasms in Southeast Iran: Results of Kerman Population-Based Cancer Registry 2014-2020.

Cancer survivors may experience a subsequent primary cancer that affects their survival and quality of life. This study aimed to investigate the epidemiology of multiple primary malignant neoplasms (M... In this retrospective cohort study, all patients who had been diagnosed with primary cancers and registered with the Kerman Cancer Registry Program (KPBCR) during 2014-2020 were included. MPMNs were d... Of 26,315 patients registered with a primary cancer diagnosis, 492 (1.86%) developed subsequent primary cancers. The most common type of secondary cancer was skin and mucosa (n=131, 26.63%) followed b... Both patients and physicians should be taught about the importance of prevention and the provision of care and screening services among cancer survivors. Studying the epidemiology, susceptibility, and...